Table 2 Comparison of the proportions of patients with different levels of ANA titers between groups.
ANA titers | SLE group (n = 148) | Non-SLE rheumatic diseases group (n = 317) | Nephropathy group (n = 99) | Hematological diseases group (n = 210) | Other diseases group (n = 523) |
|---|---|---|---|---|---|
−, n (%) | 0 | 113 (35.65) | 76 (76.77) | 129 (61.43) | 393 (75.14) |
±, n (%) | 5 (3.38) | 44 (13.88) | 17 (17.17) | 60 (28.57) | 102 (19.50) |
≥ 1 +, n (%) | 143 (96.62*) | 160 (50.47*) | 6 (6.06) | 21 (10.00) | 28 (5.35) |
≥ 2 +, n (%) | 128 (86.49*) | 98 (30.91*) | 0 | 0 | 9 (1.72) |
≥ 3 +, n (%) | 101 (68.24▲) | 37 (11.67) | 0 | 0 | 3 (0.57) |
≥ 4 +, n (%) | 11 (7.43) | 1 (0.32) | 0 | 0 | 0 |
